Efficacy of galcanezumab in patients with migraine and history of failure to 3–4 preventive medication categories: subgroup analysis from CONQUER study

Efficacy of galcanezumab in patients with migraine and history of failure to 3–4 preventive medication categories: subgroup analysis from CONQUER study

Abstract Background Chronic migraine (CM) and episodic migraine (EM) are associated with substantial headache-related disability, poor quality of life and global societal burden. In this subgroup analysis from the CONQUER study, we report efficacy outcomes from a pre-specified analysis of galcanezum...

Full description

Bibliographic Details
Main Authors: Rose Okonkwo, Antje Tockhorn-Heidenreich, Chad Stroud, Marie-Ange Paget, Manjit S. Matharu, Cristina Tassorelli
Format: Article
Language:English
Published: BMC 2021-09-01
Series:The Journal of Headache and Pain
Subjects:
Difficult-to-treat
Prior preventive
Calcitonin gene-related peptide
CGRP
Migraine headache days
Online Access:https://doi.org/10.1186/s10194-021-01322-7

Internet

https://doi.org/10.1186/s10194-021-01322-7

Similar Items